Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Flavin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|August 4, 2009
Calanolides, the naturally occurring anti-HIV agentsZ Q Xu, M T Flavin, T R Jenta
Journal of Medicinal Chemistry|February 1, 1987
Molecular modification of anticholinergics as probes for muscarinic receptors. 3. Conformationally restricted analogues of benactyzineM T Flavin, M C Lu, E B Thompson, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1984
Pharmacological properties of two amino esters of diphenylpropanoic acidE B Thompson, L B Shih, L Wu, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Biflavonoids as novel antituberculosis agentsY M Lin, M T Flavin, C S Cassidy, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse modelZ Q Xu, M G Hollingshead, S Borgel, et al.
Antiviral Research|November 7, 1998
Robustaflavone, a potential non-nucleoside anti-hepatitis B agentD E Zembower, Y M Lin, M T Flavin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2001
Amyloid fibril formation in microwell plates for screening of inhibitorsY M Lin, R Raffen, Y Zhou, et al.
Antiviral Therapy|March 21, 2000
Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptaseY Quan, D Motakis, R Buckheit, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 2000
Quantification of (+)-calanolide A, a novel and naturally occurring anti-HIV agent, by high-performance liquid chromatography in plasma from rat, dog and humanZ Q Xu, K J Norris, D S Weinberg, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjectsT Creagh, J L Ruckle, D T Tolbert, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|August 4, 2009
Calanolides, the naturally occurring anti-HIV agentsZ Q Xu, M T Flavin, T R Jenta
Journal of Medicinal Chemistry|February 1, 1987
Molecular modification of anticholinergics as probes for muscarinic receptors. 3. Conformationally restricted analogues of benactyzineM T Flavin, M C Lu, E B Thompson, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1984
Pharmacological properties of two amino esters of diphenylpropanoic acidE B Thompson, L B Shih, L Wu, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Biflavonoids as novel antituberculosis agentsY M Lin, M T Flavin, C S Cassidy, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse modelZ Q Xu, M G Hollingshead, S Borgel, et al.
Antiviral Research|November 7, 1998
Robustaflavone, a potential non-nucleoside anti-hepatitis B agentD E Zembower, Y M Lin, M T Flavin, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2001
Amyloid fibril formation in microwell plates for screening of inhibitorsY M Lin, R Raffen, Y Zhou, et al.
Antiviral Therapy|March 21, 2000
Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptaseY Quan, D Motakis, R Buckheit, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 2000
Quantification of (+)-calanolide A, a novel and naturally occurring anti-HIV agent, by high-performance liquid chromatography in plasma from rat, dog and humanZ Q Xu, K J Norris, D S Weinberg, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjectsT Creagh, J L Ruckle, D T Tolbert, et al.
Pageof 2